<article title='Cerebral_arteriovenous_malformation'><paragraph><template><target>Infobox disease</target><arg name="Name"><space/>Cerebral arteriovenous malformation
<space/></arg><arg name="Image"><space/>AVM grossly.jpg
<space/></arg><arg name="Caption"><space/>Large arteriovenous malformation of the parietal lobe
<space/></arg><arg name="DiseasesDB"><space/>2224
<space/></arg><arg name="ICD10"><space/>{{ICD10|Q|28|2|q|20}}
<space/></arg><arg name="ICD9"><space/>{{ICD9|747.81}}
<space/></arg><arg name="ICDO">
<space/></arg><arg name="OMIM"><space/>108010
<space/></arg><arg name="MedlinePlus"><space/>000779
<space/></arg><arg name="eMedicineSubj"><space/>neuro
<space/></arg><arg name="eMedicineTopic"><space/>21
<space/></arg><arg name="eMedicine_mult"><space/>{{eMedicine2|article|252426}} {{eMedicine2|article|337220}}
<space/></arg><arg name="MeshID"><space/>D002538
</arg></template></paragraph><paragraph>A<space/><bold>cerebral arteriovenous malformation (AVM)</bold><space/>is an abnormal connection between the<space/><link><target>artery</target><part>arteries</part></link><space/>and<space/><link><target>vein</target><trail>s</trail></link><space/>in the<space/><link><target>human brain</target><part>brain</part></link>.</paragraph><heading level='2'>Signs and symptoms</heading><paragraph>The most frequently observed problems, related to an AVM, are<space/><link><target>headache</target><trail>s</trail></link><space/>and<space/><link><target>seizure</target><trail>s</trail></link>, backaches, neckaches and eventual nausea, as the coagulated blood makes its way down to be dissolved in the individual's spinal fluid. It is supposed that 15% of the population, at detection, have no symptoms at all.<extension extension_name='ref' name="pmid11571210"></extension><space/>Other common symptoms are a pulsing noise in the head, progressive<space/><link><target>weakness</target></link><space/>and<space/><link><target>numbness</target></link><space/>and vision changes as well as debilitating, excruciating pain.<extension extension_name='ref' name="Mayo-Symptoms"><template><target>Cite web</target><arg name="url">http://www.mayoclinic.com/health/brain-avm/DS01126/DSECTION</arg><arg name="title">Brain AVM (arteriovenous malformation)-Symptoms<space/></arg><arg name="author">Mayo Clinic staff<space/></arg><arg name="date">February 2009</arg><arg name="publisher">Mayo Foundation for Medical Education and Research<space/></arg><arg name="accessdate">2010-05-18</arg></template></extension><extension extension_name='ref' name="Medline"></extension></paragraph><paragraph>In serious cases, the blood vessels rupture and there is bleeding within the brain (<link><target>intracranial hemorrhage</target></link>). Nevertheless in more than half of patients with AVM, hemorrhage is the first symptom.<extension extension_name='ref' name="Medline"></extension><space/>Symptoms due to bleeding include loss of consciousness, sudden and severe headache, nausea, vomiting,<space/><link><target>Urinary incontinence</target><part>incontinence</part></link>, and blurred vision, amongst others.<extension extension_name='ref' name="Mayo-Symptoms"></extension><space/>Impairments caused by local brain tissue damage on the bleed site are also possible, including seizure, one-sided weakness (<link><target>hemiparesis</target></link>), a loss of touch sensation on one side of the body and deficits in language processing (<link><target>aphasia</target></link>).<extension extension_name='ref' name="Mayo-Symptoms"></extension><space/>Minor bleeding can occur with no noticeable symptoms. Following the bleed's cessation, most AVM victims return to normal, after the blood vessel has had time to repair itself.</paragraph><paragraph>AVMs in certain critical locations may stop the circulation of the<space/><link><target>cerebrospinal fluid</target></link>, causing accumulation of the fluid within the skull and giving rise to a clinical condition called<space/><link><target>hydrocephalus</target></link>.<extension extension_name='ref' name="Medline"><template><target>Cite web</target><arg name="url">http://www.nlm.nih.gov/medlineplus/ency/article/000779.htm<space/></arg><arg name="title">Arteriovenous malformation - cerebral<space/></arg><arg name="author">David C. Dugdale, Daniel B. Hoch<space/></arg><arg name="date">October 2008</arg><arg name="publisher">ADAM<space/></arg><arg name="accessdate">2010-05-18</arg></template></extension><space/>A stiff neck can occur as the result of increased pressure within the skull and irritation of the<space/><link><target>meninges</target></link>.</paragraph><heading level='2'>Diagnosis</heading><paragraph><link><target>File:Vein of galen ax direct AV.jpg</target><part>thumb</part><part>right</part><part>Axial image from computerized tomography angiogram showing arteriovenous communication in<space/><link><target>Vein of Galen aneurysmal malformations</target><part>vein of Galen malformation</part></link></part></link><link><target>File:Vein of Galen aneurysmal malformations.TIF</target><part>thumb</part><part>Vein of Galen aneurysmal malformations</part></link>An AVM diagnosis is established by<space/><link><target>neuroimaging</target></link><space/>studies after a complete neurological and physical examination.<extension extension_name='ref' name="Medline"></extension><extension extension_name='ref' name="Mayo-Diagnosis"><template><target>Cite web</target><arg name="url">http://www.mayoclinic.com/health/brain-avm/DS01126/DSECTION</arg><arg name="title">Brain AVM (arteriovenous malformation)-Tests and diagnosis<space/></arg><arg name="author">Mayo Clinic staff<space/></arg><arg name="date">February 2009</arg><arg name="publisher">Mayo Foundation for Medical Education and Research<space/></arg><arg name="accessdate">2010-05-18</arg></template></extension><space/>Three main techniques are used to visualize the brain and search for AVM:<space/><link><target>computed tomography</target></link><space/>(CT),<space/><link><target>magnetic resonance imaging</target></link><space/>(MRI), and<space/><link><target>cerebral angiography</target></link>.<extension extension_name='ref' name="Mayo-Diagnosis"></extension><space/>A CT scan of the head is usually performed first when the subject is symptomatic. It can suggest the approximate site of the bleed.<extension extension_name='ref' name="pmid11571210"></extension><space/>MRI is more sensitive than CT in the diagnosis of AVMs and provides better information about the exact location of the malformation.<extension extension_name='ref' name="Mayo-Diagnosis"></extension><space/>More detailed pictures of the tangle of blood vessels that compose an AVM can be obtained by using radioactive agents injected into the blood stream. If a CT is used in conjunctiangiogram, this is called a computerized tomography angiogram; while, if MRI is used it is called<space/><link><target>magnetic resonance angiogram</target></link>.<extension extension_name='ref' name="pmid11571210"></extension><extension extension_name='ref' name="Mayo-Diagnosis"></extension><space/>The best images of an AVM are obtained through<space/><link><target>cerebral angiography</target></link>. This procedure involves using a<space/><link><target>catheter</target></link>, threaded through an artery up to the head, to deliver a contrast agent into the AVM. As the contrast agent flows through the AVM structure, a sequence of<space/><link><target>X-ray</target></link><space/>images are obtained.<extension extension_name='ref' name="Mayo-Diagnosis"></extension></paragraph><heading level='2'>Grading</heading><paragraph>A common method of grading cerebral AVMs is the Spetzler-Martin grade.<extension extension_name='ref'><template><target>cite journal</target><arg name="last">Spetzler</arg><arg name="first">R</arg><arg name="author2">Martin N</arg><arg name="journal">J Neurosurg</arg><arg name="year">1986</arg><arg name="volume">65</arg><arg name="pages">476â€“83</arg><arg name="pmid">3760956</arg><arg name="doi">10.3171/jns.1986.65.4.0476</arg><arg name="title">A proposed grading system for arteriovenous malformations</arg><arg name="issue">4</arg></template></extension><space/>This system was designed to assess the patient's risk of neurological deficit after open surgical resection (surgical morbidity), based on characteristics of the AVM itself. Based on this system, AVMs may be classified as grades 1 - 5. This system was not intended to characterize risk of hemorrhage.<space/></paragraph><table class="wikitable"><tablerow><tablehead>AVM size</tablehead><tablehead>Adjacent eloquent cortex</tablehead><tablehead>Draining veins</tablehead></tablerow><tablerow><tablecell>Under 3&amp;nbsp;cm = 1</tablecell><tablecell>Non-eloquent = 0</tablecell><tablecell>Superficial only = 0</tablecell></tablerow><tablerow><tablecell>36&amp;nbsp;cm = 2</tablecell><tablecell>Eloquent* = 1</tablecell><tablecell>Deep veins = 1</tablecell></tablerow><tablerow><tablecell>Over 6&amp;nbsp;cm = 3</tablecell><tablecell></tablecell><tablecell></tablecell></tablerow></table><paragraph>&quot;<link><target>Eloquent cortex</target></link>&quot; is a name used by neurologists for areas of cortex that, if removed will result in loss of sensory processing or linguistic ability, minor paralysis, or paralysis.</paragraph><paragraph>The risk of post-surgical neurological deficit (difficulty with language, motor weakness, vision loss) increases with increasing Spetzler-Martin grade.</paragraph><heading level='2'>Pathophysiology</heading><paragraph>AVMs are an abnormal connection between the arteries and veins in the human brain. Arteriovenous malformations are most commonly of<space/><link><target>prenatal</target></link><space/>origin.<extension extension_name='ref' name="Mayo-Causes"><template><target>Cite web</target><arg name="url">http://www.mayoclinic.com/health/brain-avm/DS01126/DSECTION</arg><arg name="title">Brain AVM (arteriovenous malformation)-Causes<space/></arg><arg name="author">Mayo Clinic staff<space/></arg><arg name="date">February 2009</arg><arg name="publisher">Mayo Foundation for Medical Education and Research<space/></arg><arg name="accessdate">2010-05-30</arg></template></extension><space/>The cause of AVMs remains unknown.<extension extension_name='ref' name="Mayo-Causes"></extension><space/>In a normal brain<space/><link><target>oxygen</target></link><space/>enriched blood from the heart travels in sequence through smaller blood vessels going from arteries, to<space/><link><target>arterioles</target></link><space/>and then<space/><link><target>capillary</target><part>capillaries</part></link>.<extension extension_name='ref' name="Mayo-Causes"></extension><space/>Oxygen is removed in the latter vessel to be used by the brain.<extension extension_name='ref' name="Mayo-Causes"></extension><space/>After the oxygen is removed blood reaches<space/><link><target>venules</target></link><space/>and later veins which will take it back to the heart and lungs.<extension extension_name='ref' name="Mayo-Causes"></extension><space/>On the other hand when there is an AVM blood goes directly from arteries to veins through the abnormal vessels disrupting the normal circulation of blood.<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Mouchtouris</arg><arg name="first1">Nikolaos</arg><arg name="last2">Jabbour</arg><arg name="first2">Pascal M</arg><arg name="last3">Starke</arg><arg name="first3">Robert M</arg><arg name="last4">Hasan</arg><arg name="first4">David M</arg><arg name="last5">Zanaty</arg><arg name="first5">Mario</arg><arg name="last6">Theofanis</arg><arg name="first6">Thana</arg><arg name="last7">Ding</arg><arg name="first7">Dale</arg><arg name="last8">Tjoumakaris</arg><arg name="first8">Stavropoula I</arg><arg name="last9">Dumont</arg><arg name="first9">Aaron S</arg><arg name="last10">Ghobrial</arg><arg name="first10">George M</arg><arg name="last11">Kung</arg><arg name="first11">David</arg><arg name="last12">Rosenwasser</arg><arg name="first12">Robert H</arg><arg name="last13">Chalouhi</arg><arg name="first13">Nohra</arg><arg name="title">Biology of cerebral arteriovenous malformations with a focus on inflammation</arg><arg name="journal">Journal of Cerebral Blood Flow & Metabolism</arg><arg name="date">19 November 2014</arg><arg name="volume">35</arg><arg name="issue">2</arg><arg name="pages">167â€“175</arg><arg name="doi">10.1038/jcbfm.2014.179</arg></template></extension><extension extension_name='ref' name="Mayo-Causes"></extension></paragraph><heading level='2'>Prognosis</heading><paragraph>The main risk is<space/><link><target>intracranial hemorrhage</target></link>. This risk is difficult to quantify since many patients with asymptomatic AVMs will never come to medical attention. Small AVMs tend to bleed more often than do larger ones, the opposite of cerebral aneurysms.<extension extension_name='ref'><template><target>cite journal</target><arg name="last">Crawford</arg><arg name="first">PM</arg><arg name="journal">J Neurol Neurosurg Psychiatry</arg><arg name="year">1986</arg><arg name="volume">49</arg><arg name="pages">1â€“10</arg><arg name="pmid">3958721</arg><arg name="doi">10.1136/jnnp.49.1.1</arg><arg name="title">Arteriovenous malformations of the brain: natural history in unoperated patients</arg><arg name="issue">1</arg><arg name="pmc">1028639</arg><arg name="display-authors">etal</arg></template></extension><space/>If a rupture or bleeding incident occurs, the blood may penetrate either into the brain tissue (<link><target>cerebral hemorrhage</target></link>) or into the<space/><link><target>subarachnoid space</target></link>, which is located between the sheaths (<link><target>meninges</target></link>) surrounding the brain (<link><target>subarachnoid hemorrhage</target></link>). Bleeding may also extend into the<space/><link><target>ventricular system</target></link><space/>(<link><target>intraventricular hemorrhage</target></link>). Cerebral hemorrhage appears to be most common.<extension extension_name='ref' name="pmid11571210"></extension>One long-term study (mean follow up greater than 20 years) of over 150 symptomatic AVMs (either presenting with bleeding or seizures) found the risk of cerebral hemorrhage to be approximately 4% per year, slightly higher than the 2-3% seen in other studies.<extension extension_name='ref'><template><target>cite journal</target><arg name="last">Ondra</arg><arg name="first">SL</arg><arg name="journal">J Neurosurgery</arg><arg name="year">1990</arg><arg name="volume">73</arg><arg name="pages">387â€“391</arg><arg name="pmid">2384776</arg><arg name="doi">10.3171/jns.1990.73.3.0387</arg><arg name="title">The natural history of symptomatic arteriovenous malformations of the brain: A 24-year follow-up assessment</arg><arg name="issue">3</arg><arg name="display-authors">etal</arg></template></extension><space/>A simple, rough approximation of a patient's lifetime bleeding risk is 105 - (patient age in years).<extension extension_name='ref'><template><target>cite book</target><arg name="last">Greenberg</arg><arg name="first">Mark</arg><arg name="title">Handbook of Neurosurgery (7th ed)</arg><arg name="year">2010</arg><arg name="publisher">Thieme</arg><arg name="pages">1100</arg></template></extension><space/>This equation assumes a 3% yearly bleeding risk. For example, a healthy 30-year-old patient would have approximately a 75% lifetime risk of at least one bleeding event.</paragraph><heading level='2'>Treatment</heading><paragraph>Treatment depends on the location and size of the AVM and whether there is bleeding or not.<extension extension_name='ref' name="Mayo-Treatment"><template><target>Cite web</target><arg name="url">http://www.mayoclinic.com/health/brain-avm/DS01126/DSECTION</arg><arg name="title">Brain AVM (arteriovenous malformation)-Treatments and drugs<space/></arg><arg name="author">Mayo Clinic staff<space/></arg><arg name="date">February 2009</arg><arg name="publisher">Mayo Foundation for Medical Education and Research<space/></arg><arg name="accessdate">2010-05-18</arg></template></extension></paragraph><paragraph>The treatment in the case of sudden bleeding is focused on restoration of vital function. Anticonvulsant medications such as<space/><link><target>phenytoin</target></link><space/>are often used to control seizure; medications or procedures may be employed to relieve intracranial pressure. Eventually, curative treatment may be required to prevent recurrent hemorrhage. However, any type of intervention may also carry a risk of creating a neurological deficit.<template><target>Citation needed</target><arg name="date">May 2010</arg></template></paragraph><paragraph>Preventive treatment of as yet unruptured brain AVMs has been controversial, as several studies suggested favorable long-term outcome for unruptured AVM patients not undergoing intervention. The NIH-funded longitudinal ARUBA study (&quot;A Randomized trial of Unruptured Brain AVMs) compares the risk of stroke and death in patients with preventive AVM eradication versus those followed without intervention.<extension extension_name='ref' name="aruba01"></extension><space/>Interim results suggest that fewer strokes occur as long as patients with unruptured AVM do not undergo intervention. Because of the higher than expected event rate in the interventional arm of the ARUBA study, NIH/NINDS has stopped patient enrollment in April 2013, while continuing to follow all participants to determine whether the difference in stroke and death in the two arms changes over time.<extension extension_name='ref' name="aruba02"></extension></paragraph><paragraph>Surgical elimination of the blood vessels involved is the preferred curative treatment for many types of AVM.<extension extension_name='ref' name="Mayo-Treatment"></extension><space/>Surgery is performed by a<space/><link><target>neurosurgeon</target></link><space/>who temporarily removes part of the skull (<link><target>craniotomy</target></link>), separates the AVM from surrounding brain tissue, and resects the abnormal vessels.<extension extension_name='ref' name="Mayo-Treatment"></extension><space/>While surgery can result in an immediate, complete removal of the AVM, risks exist depending on the size and the location of the malformation. The preferred treatment of Spetzler-Martin grade 1 and 2 AVMs in young, healthy patients is surgical resection due to the relatively small risk of neurological damage compared to the high lifetime risk of hemorrhage. Grade 3 AVMs may or may not be amenable to surgery. Grade 4 and 5 AVMs are not usually surgically treated.<extension extension_name='ref'><template><target>cite journal</target><arg name="last">Starke</arg><arg name="first">RM</arg><arg name="journal">Br J Neurosurg</arg><arg name="year">2009</arg><arg name="volume">23</arg><arg name="pages">376â€“86</arg><arg name="pmid">19637008</arg><arg name="doi">10.1080/02688690802562663</arg><arg name="title">Treatment guidelines for cerebral arteriovenous malformation microsurgery</arg><arg name="issue">4</arg><arg name="display-authors">etal</arg></template></extension></paragraph><paragraph><link><target>Radiosurgery</target></link><space/>has been widely used on small AVMs with considerable success. The<space/><link><target>Gamma Knife</target></link><space/>is an apparatus used to precisely apply a controlled radiation dosage to the volume of the brain occupied by the AVM. While this treatment does not require an incision and craniotomy (with their own inherent risks), three or more years may pass before the complete effects are known, during which time patients are at risk of bleeding.<extension extension_name='ref' name="Mayo-Treatment"></extension><space/>Complete obliteration of the AVM may or may not occur after several years, and repeat treatment may be needed. Radiosurgery is itself not without risk. In one large study, nine percent of patients had transient neurological symptoms, including headache, after radiosurgery for AVM. However, most symptoms resolved, and the long-term rate of neurological symptoms was 3.8%.<extension extension_name='ref'><template><target>cite journal</target><arg name="last">Flickinger</arg><arg name="first">JC</arg><arg name="journal">Int J Radiat Oncol Biol Phys</arg><arg name="year">1998</arg><arg name="volume">40</arg><arg name="pages">273â€“278</arg><arg name="pmid">9457809</arg><arg name="doi">10.1016/S0360-3016(97)00718-9</arg><arg name="title">Analysis of neurological sequelae from radiosurgery of arteriovenous malformations: How location affects outcome</arg><arg name="issue">2</arg><arg name="display-authors">etal</arg></template></extension></paragraph><paragraph><link><target>Embolization</target></link><space/>is the occlusion of blood vessels most commonly with a glue-like substance introduced by a<space/><link><target>Radiology</target><part>radiographically</part></link><space/>guided<space/><link><target>catheter</target></link>.<extension extension_name='ref' name="Mayo-Treatment"></extension><space/>Such glue blocks the vessel and reduces blood flow into the AVM.<extension extension_name='ref' name="Mayo-Treatment"></extension><space/>Embolization is frequently used as an adjunct to either surgery or radiation treatment.<extension extension_name='ref' name="Mayo-Treatment"></extension><space/>Before other treatments it reduces the size of the AVM while during surgery it reduces the risk of bleeding.<extension extension_name='ref' name="Mayo-Treatment"></extension><space/>However, embolization alone may completely obliterate some AVMs. In high flow intranidal fistula we can use balloon to reduce the flow so that embolization can be done safely.<extension extension_name='ref'>Huded V. Endovascular balloon-assisted glue embolization of intranidal high flow fistula in brain AVM. J Neurosci Rural Pract 2013;4, Suppl S1:148-9</extension></paragraph><heading level='2'>Epidemiology</heading><paragraph>The annual new detection rate<space/><link><target>incidence (epidemiology)</target><part>incidence</part></link><space/>of AVMs is approximately 1 per 100,000 a year. The<space/><link><target>point prevalence</target></link><space/>in adults is approximately 18 per 100,000.<extension extension_name='ref' name="pmid11571210"><template><target>Cite journal</target><arg name="author">Al-Shahi R, Warlow C<space/></arg><arg name="title">A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults<space/></arg><arg name="journal">Brain<space/></arg><arg name="volume">124<space/></arg><arg name="issue">Pt 10<space/></arg><arg name="pages">1900â€“26<space/></arg><arg name="date">October 2001<space/></arg><arg name="pmid">11571210<space/></arg><arg name="doi"><space/>10.1093/brain/124.10.1900</arg><arg name="url">http://brain.oxfordjournals.org/cgi/content/full/124/10/1900?view</arg><arg name="accessdate">2010-05-18</arg></template></extension><space/>AVMs are more common in males than females, although in females<space/><link><target>pregnancy</target></link><space/>may start or worsen symptoms due the increase in<space/><link><target>blood flow</target></link><space/>and<space/><link><target>blood volume</target><part>volume</part></link><space/>it usually brings.<extension extension_name='ref' name="Mayo-RF"><template><target>Cite web</target><arg name="url">http://www.mayoclinic.com/health/brain-avm/DS01126/DSECTION</arg><arg name="title">Brain AVM (arteriovenous malformation)-Risk factors<space/></arg><arg name="author">Mayo Clinic staff<space/></arg><arg name="date">February 2009</arg><arg name="publisher">Mayo Foundation for Medical Education and Research<space/></arg><arg name="accessdate">2010-05-30</arg></template></extension></paragraph><heading level='2'>Research directions</heading><paragraph>No randomized, controlled clinical trial has established a survival benefit for treating patients (either with open surgery or radiosurgery) with AVMs that have not yet bled.<extension extension_name='ref' name="ARUBA"><template><target>Cite web</target><arg name="url">http://arubastudy.org/</arg><arg name="title">The ARUBA trial-A Randomized Trial of Unruptured Brain Arteriovenous Malformations</arg><arg name="accessdate">2010-05-30</arg></template></extension></paragraph><heading level='2'>References</heading><paragraph><extension extension_name='references'><extension extension_name='ref' name="aruba01"><template><target>cite web</target><arg name="title"><space/>Official ARUBA study website (english)<space/></arg><arg name="url"><space/>http://www.arubastudy.org/<space/></arg><arg name="accessdate"><space/>2011-12-13</arg></template></extension><extension extension_name='ref' name="aruba02"><template><target>cite web</target><arg name="title"><space/>Official interim results of ARUBA trial (english)<space/></arg><arg name="url"><space/>http://www.ninds.nih.gov/news_and_events/news_articles/ARUBA_trial_results.htm<space/></arg><arg name="accessdate"><space/>2013-05-13</arg></template></extension></extension></paragraph><heading level='2'>External links</heading><paragraph><template><target>Commons category</target><arg>Cerebral arteriovenous malformation</arg></template></paragraph><list type='bullet'><listitem><link type='external' href='http://www.taafonline.org/'>The Aneurysm and AVM Foundation (TAAF)</link></listitem></list><paragraph><template><target>Congenital vascular defects</target></template></paragraph><paragraph><template><target>DEFAULTSORT:Cerebral Arteriovenous Malformation</target></template><link><target>Category:Anatomical pathology</target></link><link><target>Category:Congenital vascular defects</target></link></paragraph></article>